Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Thrombotic microangiopathy? 149 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Thrombotic microangiopathy have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.

149
Reports of Thrombotic microangiopathy with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
32
Deaths
86
Hospitalizations

How Dangerous Is Thrombotic microangiopathy From LENALIDOMIDE?

Of the 149 reports, 32 (21.5%) resulted in death, 86 (57.7%) required hospitalization, and 29 (19.5%) were considered life-threatening.

Is Thrombotic microangiopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 149 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Thrombotic microangiopathy?

TACROLIMUS (1,982) MYCOPHENOLATE MOFETIL (820) CYCLOSPORINE (724) GEMCITABINE (648) ECULIZUMAB (636) CYCLOPHOSPHAMIDE (602) FLUDARABINE (480) METHOTREXATE (447) CARFILZOMIB (350) METHYLPREDNISOLONE (345)

Which LENALIDOMIDE Alternatives Have Lower Thrombotic microangiopathy Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Thrombotic microangiopathy Reports All Drugs Causing Thrombotic microangiopathy LENALIDOMIDE Demographics